In CASE 11

In CASE 11.1 Association for Molecular Pathology v.Myriad Genetics,Inc.(2013) ,the U.S.Supreme Court held that under U.S.Patent Laws isolated DNA is:

A) not eligible for patent protection because it is naturally occurring.
B) eligible for patent protection because it is man-made.
C) eligible for patent protection because it is naturally occurring.
D) not eligible for patent protection because it is man-made.